Menu
The Instituto Nacional de Câncer registered cervical cancer as the third most common tumor affecting women in Brazil in 2023, while clinical...
New research has revealed that the HPV vaccine has been crucial in drastically reducing deaths from cervical cancer among young women in...
The introduction of regular immunization against the human papillomavirus (HPV) in England resulted in an almost complete reduction in the risk of...
Cervical cancer is among the malignant tumors with the highest incidence in the female population. Persistent infection with specific strains of Papilomavírus...
Cervical cancer is among the malignant tumors with the highest incidence in the female population worldwide. Persistent infection with specific strains of...
Researchers at Instituto Karolinska, a world reference in medicine located at Suécia, have presented compelling new evidence on the long-term effectiveness of...
New scientific evidence consolidated by researchers from Instituto Karolinska, in Suécia, brought decisive confirmations about the prolonged effectiveness of immunization against the...
A comprehensive survey conducted by researchers at Instituto Karolinska in Suécia has provided new evidence on the long-term effectiveness of immunization against...
A comprehensive survey by Instituto Karolinska scientists at Suécia has consolidated evidence on the long-term effectiveness of human papillomavirus (HPV) vaccination. The...
A large study led by Swedish researchers has shown that the human papillomavirus (HPV) vaccine offers long-lasting protection against invasive cervical cancer,...
Sua privacidade
O Mix Vale usa cookies para medir audiência e exibir anúncios que sustentam a redação. Você escolhe. Saiba mais.